Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects with Heart Failure and Reduced Ejection Fraction
Study of OPTIMIZER System in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF)
Sponsor: Impulse Dynamics, Inc
Enrolling: Male and Female Patients
IRB Number: AAAT9371
U.S. Govt. ID: NCT05855135
Contact: Esteban Ceballos: /
Additional Study Information: You may want to join this study because your heart condition may respond to a device-based therapy called cardiac modulation therapy, CCM therapy, called the OPTIMIZER System.
Hirad Yarmohammadi, MD, MPH
Do You Qualify?
Are you at least 18 years old? Yes No
Have you been diagnosed with Heart Failure with Reduced Ejection Fraction (HFrEF)? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Esteban Ceballos